Breakthrough for AlzeCure in the development of drugs for nerve pain

AlzeCure Pharma shows positive results from its clinical study with a new non-opioid drug candidate developed against peripheral neuropathic pain.

AlzeCure Pharma’s CEO Martin Jönsson.

New data from AlzeCure’s phase IIa study show that the drug candidate ACD440 has a significant analgesic effect on pain induced by cold and heat.

– The medical need in this area is immense, not least to find alternatives to opioids. Neuropathic pain is the single largest market segment in pain management, generating over $11 billion in annual revenues. Up to 80 percent of all patients do not get a satisfactory effect with their current treatments, said AlzeCure Pharma’s CEO Martin Jönsson.

AlzeCure is among a handful of companies in the world that develop drugs that target the TRPV1 receptor, whose discovery was awarded the 2021 Nobel Prize in Medicine. The goal is to help people who suffer from nerve pain. In many cases today, there is no other effective treatment available than opioids, which both numb the whole body and can lead to addiction and substance abuse.

Novum – More Than a Place

The Park and the real estate company Hemsö have entered into a collaboration which means Novum Research Park in Flemingsberg will offer a first-class coworking environment for researchers, innovators, and creative minds who want to become part of a growing Life Science cluster. At the same time, the Flemingsberg Science Foundation is launching a film about Novum—playful and with a touch of drama.

Time to Apply for This Year’s Idea Competition – Flemingsberg Science Award Idea!

Maybe you’ve been carrying an idea for a long time—a spark you believe could create something new, clever, and beneficial for society. Now it’s time to give your dream a chance to become reality.

Academic Alliance to Shape the Future of Game Development in Flemingsberg

The game initiative Press Start Game Hub in Flemingsberg has now taken a major step forward in developing a sustainable game development ecosystem by launching its first academic collaboration group: Press Start Academic Group. The first meeting was held in June 2025 and brought together researchers and key figures from some of Sweden’s most prominent game development programs.